Skip to main content

Peer Review reports

From: Validation and prognostic value of EZ-ALBI score in patients with intermediate-stage hepatocellular carcinoma treated with trans-arterial chemoembolization

Original Submission
24 Mar 2022 Submitted Original manuscript
9 Apr 2022 Author responded Author comments - Supachaya Sriphoosanaphan
12 Apr 2022 Author responded Author comments - Supachaya Sriphoosanaphan
Resubmission - Version 2
9 Apr 2022 Submitted Manuscript version 2
30 Apr 2022 Reviewed Reviewer Report
8 May 2022 Reviewed Reviewer Report
24 May 2022 Author responded Author comments - Supachaya Sriphoosanaphan
Resubmission - Version 3
24 May 2022 Submitted Manuscript version 3
24 May 2022 Author responded Author comments - Supachaya Sriphoosanaphan
Resubmission - Version 4
24 May 2022 Submitted Manuscript version 4
25 May 2022 Author responded Author comments - Supachaya Sriphoosanaphan
Resubmission - Version 5
25 May 2022 Submitted Manuscript version 5
29 May 2022 Reviewed Reviewer Report
Resubmission - Version 6
Submitted Manuscript version 6
Publishing
2 Jun 2022 Editorially accepted
14 Jun 2022 Article published 10.1186/s12876-022-02366-y

You can find further information about peer review here.

Back to article page